- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05792202
Combined Microfracture Procedure Promotes Tendon Healing
April 25, 2024 updated by: Yi Lu, Beijing Jishuitan Hospital
Combined Microfracture Procedure Promotes Tendon Healing During Double Raw Repair for Full Tear Rotator Cuff - a Prospective Randomized Study With 2-year Follow-up
This study is a prospective randomized controlled study of Combined microfracture procedure promotes tendon healing during double raw repair for full tear rotator cuff.
The patients with rotator cuff tear were randomly divided into groups before the operation.
The patients were followed up before and 6 weeks, 3 months, 6 months, 12 months after surgery.
In different time periods, the quantitative and qualitative indicators including pain, functional score, muscle strength, MRI performance, etc. were compared between groups at the same time period to evaluate the difference in the effect of Crimson duvet procedure with Greenhouse procedure on the treatment of rotator cuff.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Shangzhe Li, M.D.
- Phone Number: +86 13826162999
- Email: 562744381@qq.com
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100000
- Recruiting
- Beijing Jishuitan hospital
-
Contact:
- Shangzhe Li, M.D.
- Phone Number: +86 13826162999
- Email: 562744381@qq.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Arthroscopy confirmed small to medium full rotator cuff tear
- Unilateral rotator cuff injury
- Voluntarily accept randomized controlled grouping, cooperate with treatment and follow up patients
- Young and middle-aged patients aged 20 to 60
Exclusion Criteria:
- Previous shoulder surgery (incision or arthroscopy)
- Combined with diseases of other parts of the same limb
- Combined with Bankart injury, acromioclavicular joint disease, greater tuberosity fracture, glenoid fracture and so on
- Bilateral onset
- Unable or unwilling to receive clinical follow-up
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Study group
double raw repair for full tear rotator cuff combined microfracture procedure
|
double raw repair combined with microfracture procedure which promotes tendon healing by releasing growth factors
|
Placebo Comparator: Control group
double raw repair for full tear rotator cuff
|
the double raw repair was used to repair the tendon tear
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
rotator cuff re-tear rate
Time Frame: 2 year postoperatively
|
the rotator cuff re-tear rate was measured by MRI, MRI was performed to identify the status of the tendon
|
2 year postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
front extension, external rotation and internal rotation strength of shoulder
Time Frame: 6,12,24 months postoperatively
|
Use a dynamometer to measure in N
|
6,12,24 months postoperatively
|
VAS (Visual Analogue Scale)
Time Frame: 1,2,3,7 days postoperatively and 3,6,12,24 months postoperatively, higher scores mean a worse outcome.
|
A score used to evaluate the pain
|
1,2,3,7 days postoperatively and 3,6,12,24 months postoperatively, higher scores mean a worse outcome.
|
ASES(American Shoulder and Elbow Surgeons'Form)
Time Frame: 3,6,12,24 months postoperatively
|
A score used to evaluate the shoulder function, higher scores mean a better outcome.
|
3,6,12,24 months postoperatively
|
Constant score
Time Frame: 3,6,12,24 months postoperatively
|
A score used to evaluate the shoulder function, higher scores mean a better outcome.
|
3,6,12,24 months postoperatively
|
UCLA (University LosAngeles scoring system)
Time Frame: 3,6,12,24 months postoperatively
|
A score used to evaluate the shoulder function, higher scores mean a better outcome.
|
3,6,12,24 months postoperatively
|
SST (simple shoulder test)
Time Frame: 3,6,12,24 months postoperatively
|
A score used to evaluate the shoulder function, higher scores mean a better outcome.
|
3,6,12,24 months postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2022
Primary Completion (Estimated)
March 1, 2026
Study Completion (Estimated)
June 1, 2026
Study Registration Dates
First Submitted
March 18, 2023
First Submitted That Met QC Criteria
March 18, 2023
First Posted (Actual)
March 31, 2023
Study Record Updates
Last Update Posted (Estimated)
April 29, 2024
Last Update Submitted That Met QC Criteria
April 25, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LY
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Full Rotator Cuff Tear
-
University of MichiganCompletedFull Thickness Rotator Cuff Tear
-
Johannes Kepler University of LinzCompletedFull Thickness Rotator Cuff TearAustria
-
Lawson Health Research InstituteCompleted
-
Orthofix Inc.TerminatedPEMF as Adjunctive Treatment Following Surgical Repair of Full Thickness Rotator Cuff Tears (RCStim)Full-thickness Rotator Cuff TearUnited States
-
BioMimetic TherapeuticsCompletedFull Thickness Rotator Cuff TearCanada
-
University of Southern CaliforniaCompletedFull Thickness Rotator Cuff TearUnited States
-
Helsingborgs HospitalCompletedFull Thickness Rotator Cuff TearSweden
-
Rush University Medical CenterActive, not recruitingFull Thickness Rotator Cuff TearUnited States
-
Orthopedic Institute, Sioux Falls, SDCompletedFull Thickness Rotator Cuff TearUnited States
-
Unity Health TorontoUniversity Health Network, Toronto; Sunnybrook Health Sciences CentreUnknownFull Thickness Rotator Cuff TearCanada
Clinical Trials on microfracture procedure
-
TBF Genie TissulaireTerminatedOsteochondral Defect | Knee ChondralBelgium
-
Zealand University HospitalSuspended
-
The Catholic University of KoreaUnknown
-
Bergen Orthopedic Study GroupCompleted
-
Histogenics CorporationTerminatedArticular Cartilage Defects in the Knee JointUnited States, Canada
-
Sewon Cellontech Co., Ltd.UnknownOsteoarthritis | Defect of Articular Cartilage | Traumatic ArthritisKorea, Republic of
-
L&C BioActive, not recruitingOsteoarthritis, KneeKorea, Republic of
-
Nova Scotia Health AuthorityWithdrawnDisorder of Hip Region
-
HistogenUnited States Department of DefenseTerminatedCartilage Damage | Articular Cartilage Disorder of Knee | MicrofracturesUnited States
-
L&C BioActive, not recruitingOsteoarthritis, KneeKorea, Republic of